Amended and Restated License and Supply AgreementLicense and Supply Agreement • July 6th, 2021 • Biofrontera Inc. • Pharmaceutical preparations • Delaware
This Amended and Restated License and Supply Agreement (the “Amendment”) is made effective as of June 16, 2021, by and between Biofrontera Pharma GmbH, a German corporation with its principal offices at Hemmelrather Weg 201, 51377 Leverkusen, Germany (“PHARMA”), Biofrontera Bioscience GmbH, a German corporation with its principal offices at Hemmelrather Weg 201, 51377 Leverkusen, Germany (“BIOSCIENCE”) and Biofrontera Inc., a Delaware corporation with its principal place of business at 120 Presidential Way, Suite 330, Woburn, MA 01801, USA (“INC”). PHARMA and INC may collectively be referred to as the “Original Parties.” PHARMA, BIOSCIENCE, and INC may collectively be referred to as the “Parties” or individually as a “Party.” Capitalized terms used but not defined herein shall have the meanings assigned to them in the LSA.
MASTER CONTRACT SERVICES AGREEMENTMaster Contract Services Agreement • July 6th, 2021 • Biofrontera Inc. • Pharmaceutical preparations • Massachusetts
THIS MASTER CONTRACT SERVICES AGREEMENT (together with any Statement(s) of Work, the “Agreement”) is made as of July 2, 2021 (the “Effective Date”) by and between Biofrontera, Inc., a company with an office at 120 Presidential Way, Suite 330, Woburn, MA 01801 (“COMPANY”) and Biofrontera AG, a German corporation with a principal office at Hemmelrather Weg 201, 51377 Leverkusen, together with its wholly owned subsidiaries Biofrontera Pharma GmbH, a German company with a principal office at Hemmelrather Weg 201, 51377 Leverkusen, and Biofrontera Bioscience GmbH, a German company with a principal office at Hemmelrather Weg 201, 51377 Leverkusen (collectively, the “Service Provider”). Throughout this Agreement, COMPANY and Service Provider may be referred to as a “Party” or collectively as the “Parties.”
EMPLOYMENT AGREEMENTEmployment Agreement • July 6th, 2021 • Biofrontera Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement (the “Agreement”) is made as of October 21, 2019 by and between Biofrontera, Inc, a Delaware corporation (the “Company”) having its registered office at 120 Presidential Way, Suite 330, Woburn, MA 01801 and Erica Monaco (the “Executive”) currently employed as Vice President of Finance and Operations for Biofrontera Inc.
SECOND INTERCOMPANY REVOLVING LOAN AGREEMENTSecond Intercompany Revolving Loan Agreement • July 6th, 2021 • Biofrontera Inc. • Pharmaceutical preparations
THIS SECOND INTERCOMPANY REVOLVING LOAN AGREEMENT (this “Loan Agreement”) is made effective as of March 31, 2021 by and between Biofrontera Inc., a Delaware corporation with a principal office located at 120 Presidential Way, Woburn, MA 01801 USA (the “Borrower”) and Biofrontera AG, a German stock corporation registered under HRB 49717 at the lower court of Cologne and having its principal offices at Hemmelrather Weg 201, 51377 Leverkusen, Germany (the “Lender”) Lender and Borrower may sometimes be referred to as the “Parties”.
